Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2026-01-02 @ 3:45 AM
Study NCT ID:
NCT05545969
Status:
WITHDRAWN
Last Update Posted:
2024-06-26
First Post:
2022-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma
Sponsor:
Organization: